T-DM1 and mTOR inhibitor everolimus demonstrated synergistic activity at inhibiting cell proliferation. »
03/31/25

FABP4 effect associated with increased ERK phosphorylation. »
03/30/25

Data support omitting CLND in stage III CM. »
03/29/25

Importance of recognising different skin types and skin tones. »
03/29/25

Samples demonstrated co-occurrence of MSI and Eh-lectin. »
04/10/25

Cancer patients receiving ACT had shorter mean time to alleviation of symptoms. »
04/09/25

Patients who received monotherapy older and had worse performance status. »
04/09/25

Significant upregulation of most DNA damage repair genes in HBOC patients. »
04/09/25

Median PFS for DRD greater at 23.64 months compared to KRD. »
04/09/25

In common EGFR-mutated nodules, aggressive histological components rarer. »
04/09/25